Market Insights Health OTC Pharmaceuticals

Other OTC Pharmaceuticals - India

India

In India, the revenue generated in the Other OTC Pharmaceuticals market in 2024 amounts to INR €154.20.
This market is projected to experience an annual growth rate of 2.57% (CAGR 2024-2029).
When compared globally, the in the United States leads in revenue generation, with a total of €6,581.00 in 2024.
Considering the population figures, the per person revenue in India for the year 2024 stands at INR €0.11.
India's growing demand for herbal and Ayurvedic medicines is driving the growth of the Other OTC Pharmaceuticals market.

Key regions: United States, Brazil, Europe, Canada, United Kingdom

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Other OTC Pharmaceuticals market in India is experiencing significant growth due to customer preferences, market trends, local special circumstances, and underlying macroeconomic factors.Customer preferences in the Indian market play a crucial role in the development of the Other OTC Pharmaceuticals sector. With a large population and increasing disposable income, consumers in India are becoming more health-conscious and proactive in managing their healthcare needs. They are increasingly seeking accessible and affordable options for self-medication, leading to a rise in demand for over-the-counter pharmaceutical products. Additionally, the convenience of purchasing OTC medications without a prescription is appealing to customers who prefer to avoid the time and cost associated with visiting a doctor.Trends in the Indian market are also contributing to the growth of the Other OTC Pharmaceuticals sector. The increasing penetration of internet and smartphones has made information about healthcare products easily accessible to consumers. This has empowered them to make informed decisions about their health and explore a wider range of OTC products. E-commerce platforms have also played a significant role in expanding the reach of OTC pharmaceuticals, allowing customers to conveniently purchase products online and have them delivered to their doorstep.Local special circumstances in India have created a conducive environment for the development of the Other OTC Pharmaceuticals market. The presence of a robust retail network, including pharmacies and drugstores, ensures easy availability of OTC products across the country. Additionally, the regulatory framework in India allows for a wide range of OTC medications to be sold without a prescription, further driving the growth of the market. The government's focus on promoting self-care and reducing the burden on healthcare infrastructure has also contributed to the expansion of the Other OTC Pharmaceuticals sector.Underlying macroeconomic factors in India are supporting the growth of the Other OTC Pharmaceuticals market. The country's strong economic growth and rising middle-class population have led to an increase in disposable income, enabling consumers to spend more on healthcare products. The growing awareness about preventive healthcare and the importance of self-medication has further boosted the demand for OTC pharmaceuticals. Additionally, the government's initiatives to improve healthcare access and affordability have created a favorable environment for the development of the sector.In conclusion, the Other OTC Pharmaceuticals market in India is experiencing significant growth driven by customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. The increasing health-consciousness of consumers, the availability of information and convenient purchasing options, the supportive regulatory framework, and the favorable macroeconomic environment are all contributing to the development of the market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.